Liquidia (LQDA) Interest & Investment Income (2020 - 2026)

Liquidia's (LQDA) quarterly Interest & Investment Income came in at $1.8 million in Q1 2026, up 2.55% year-on-year from $1.7 million in Q1 2025, and up 6.3% quarter-over-quarter from $1.7 million in Q4 2025.

Liquidia (LQDA) Interest & Investment Income (2020 - 2026) Analysis & Trends

Liquidia's Interest & Investment Income history runs 7 years deep, the most recent figure standing at $1.8 million for Q1 2026.

  • On a quarterly basis, Interest & Investment Income rose 2.55% year-over-year to $1.8 million in Q1 2026; TTM through Mar 2026 was $6.7 million, a 11.12% decrease from a year earlier, with the FY2025 full-year figure at $6.6 million, down 13.46% from the prior year.
  • Interest & Investment Income improved to $1.8 million in Q1 2026 per LQDA's latest filing, from $1.7 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $2.1 million in Q4 2024 and bottomed at $4000.0 in Q1 2022.
  • The 5-year median for Interest & Investment Income is $1.6 million (2025), against an average of $1.2 million.
  • Across the five-year window, Interest & Investment Income plunged 80.95% in 2022 and jumped 22950.0% in 2023, its largest moves.
  • Year by year, Interest & Investment Income stood at $662000.0 in 2022, then soared by 43.2% to $948000.0 in 2023, then surged by 121.94% to $2.1 million in 2024, then decreased by 20.77% to $1.7 million in 2025, then increased by 6.3% to $1.8 million in 2026.
  • Per Business Quant, the three latest LQDA Interest & Investment Income figures stand at $1.8 million (Q1 2026), $1.7 million (Q4 2025), and $1.6 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn -
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 32.85 Mn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 41.80 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 28.10 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -
10 Liquidia 7.47 Bn 7.25 Bn 121.79 Mn 1.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.77 Mn
Dec 31, 2025 1.67 Mn
Sep 30, 2025 1.65 Mn
Jun 30, 2025 1.58 Mn
Mar 31, 2025 1.73 Mn
Dec 31, 2024 2.10 Mn
Sep 30, 2024 1.82 Mn
Jun 30, 2024 1.86 Mn
Mar 31, 2024 1.88 Mn
Dec 31, 2023 948,000.00
Sep 30, 2023 862,000.00
Jun 30, 2023 734,000.00
Mar 31, 2023 922,000.00
Dec 31, 2022 662,000.00
Sep 30, 2022 359,000.00
Jun 30, 2022 65,000.00
Mar 31, 2022 4,000.00
Dec 31, 2021 3,000.00
Sep 30, 2021 4,000.00
Jun 30, 2021 5,000.00